- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.14: 3 residues within 4Å:- Chain A: N.693
- Chain B: I.778, Y.780
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: A.690, N.1058
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain A: N.641
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain A: N.600, T.602
- Chain B: Q.820
Ligand excluded by PLIPNAG.18: 3 residues within 4Å:- Chain A: E.265, N.266
- Chain C: K.542
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain A: N.107, T.109, N.110, E.136
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain B: N.693
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain B: A.690, E.1056, N.1058
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain B: N.600, E.603, Q.628
- Chain C: Q.820
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain B: N.264, E.265, N.266
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain B: N.315, P.563, Q.564, L.566
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain A: Y.780
- Chain C: N.693
Ligand excluded by PLIPNAG.26: 5 residues within 4Å:- Chain A: Q.820, D.823
- Chain C: N.600, T.602, E.603
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain C: N.264, E.265, N.266
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain C: N.107, T.109, N.110, V.112
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, T. et al., Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529. Science (2022)
- Release Date
- 2022-03-30
- Peptides
- Spike glycoprotein: ABC
Heavy chain of antibody A19-46.1: DHJ
Light chain of antibody A19-46.1: EIK
heavy chain of antibody B1-182.1: FLN
Light chain of antibody B1-182.1: GMO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DH
HJ
ME
EI
LK
NF
JL
ON
FG
KM
PO
G
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-3-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, T. et al., Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529. Science (2022)
- Release Date
- 2022-03-30
- Peptides
- Spike glycoprotein: ABC
Heavy chain of antibody A19-46.1: DHJ
Light chain of antibody A19-46.1: EIK
heavy chain of antibody B1-182.1: FLN
Light chain of antibody B1-182.1: GMO - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DH
HJ
ME
EI
LK
NF
JL
ON
FG
KM
PO
G